Induction of an antibody response in mice against human papillomavirus (HPV) type 16 after immunization with HPV recombinant Salmonella strains

Cancer Immunology Immunotherapy

Volumn 43, Issue 1, 1996, Pages 44-48

  Krul, Mark R L ^a   Tijhaar, Edwin J ^b   Kleijne, John A F W ^c   Van Loon, Anton M ^c   Nievers, Mirjam G ^c   Schipper, Hans ^c   Geerse, Liesbeth ^c   Van Der Kolk, Mike ^c   Steerenberg, Peter A ^c   Mooi, Frits R ^c   Den Otter, Willem ^d  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^b UNIVERSITY OF ST ANDREWS   (United Kingdom)

^c NATIONAL INSTITUTE FOR PUBLIC HEALTH AND THE ENVIRONMENT   (Netherlands)

^d UTRECHT UNIVERSITY   (Netherlands)

Author keywords

Cancer; Human papilloma virus; Salmonella typhimurium; Vaccine

Indexed keywords

LIVE VACCINE; SALMONELLOSIS VACCINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; FEMALE; IMMUNIZATION; IMMUNOSTIMULATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; SALMONELLA TYPHIMURIUM; UTERINE CERVIX CARCINOMA; WART VIRUS;

ANTIBODIES, VIRAL; ANTIBODY FORMATION; BACTERIAL VACCINES; GENES, VIRAL; PAPILLOMAVIRIDAE; RECOMBINANT PROTEINS; RECOMBINATION, GENETIC; SALMONELLA INFECTIONS; SALMONELLA PHAGES; SALMONELLA TYPHIMURIUM; VACCINES, SYNTHETIC;

EID: 10244250350     PISSN: 03407004     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002620050302     Document Type: Article

References (31)

1. Alloub MI, Barr BBB, McClaren KM, Smith IW, Bunney MH, Smart GE (1989) Human papillomavirus infection and cervical intraepithelial neoplasia in women with renal allografts. Br Med J 298:153
2. Bleui C, Muller M, Frank R, Gausepohl H, Koldovsky U, Mgaya HN, Luande J, Pawlita M, ter Meulen J, Viscidi R (1991) Human papillomavirus type 18 E6 and E7 antibodies in human sera: increased anti-E7 prevalence in cervical cancer patients. J Clin Microbiol 29: 1579-1588
3. Bosch FX, Schwarz E, Boukamp P, Fusenig NE, Bartsch D, zur Hausen H (1990) Suppression in vivo of human papillomavirus type 18 E6-E7 gene expression in nontumorigenic HeLa X fibroblast hybrid cells. J Virol 64: 4743-4754
4. Brown A, Hormaeche CE, Demarco de Hormaeche R, Winther M, Dougan G, Maskell DJ, Stocker BA (1987) An attenuated aroA Salmonella typhimurium vaccine elicits humoral and cellular immunity to cloned beta-galactosidase in mice. J Infect Dis 155: 86-92
5. Campo MS (1991) Vaccination against papillomavirus. (review). Cancer Cells 3: 421-426
6. Chatfield S, Strugnell RA, Dougan G (1989) Live Salmonella as vaccines and carriers of foreign antigenic determinants. Vaccine 7: 495
7. Chatfield SN, Charles IG, Makoff AJ, Oxer MD, Dougan G, Pickard D, Slater D, Fairweather NF (1992) Use of the NirB promoter to direct the stable expression of heterologous antigens in Salmonella oral vaccine strains: development of a single-dose oral tetanus vaccine. Bio/Technology 10: 888-892
8. Crook T, Morgenstern JP, Crawford L, Banks L (1989) Continued expression of HPV-16 E7 protein is required for maintenance of the transformed phenotype of cells co-transformed by HPV-16 plus EJ-ras. EMBO J 8: 513-519
9. Feltkamp MCW, Smits HL, Vierboom MPM, Minnaar RP, Dejongh BM, Drijfhout JW, Terschegget J, Melief CJM, Kast WM (1993) Vaccination with cytotoxic T-lymphocyte epitope-containing peptide protects against a tumor induced by human papillomavirus type-16-transformed cells. Eur J Immunol 23: 2242-2249
10. Feltkamp MC, Vreugdenhil GR, Vierboom MP, Ras E, Burg SH van der, Schegget J ter, Melief CJ, Kast WM (1995) Cytotoxic T lymphocytes raised against a subdominant epitope offered as a synthetic peptide eradicate human papillomavirus type 16-induced tumors. Eur J Immunol 25: 2638-2642
11. Flynn JL, Weis WR, Norris KA, Seifert HS, Kumar S, So M (1990) Generation of a cytotoxic T-lymphocyte response using a Salmonella antigen delivery system. Mol Microbiol 4: 2111-2118
12. Gonzalez C, Hone D, Noriega FR, Tacket CO, Davis JR, Losonsky G, Nataro JP, Hoffman S, Malik A, Nardin E, Sztein MB, Heppner G, Fouts TR, Isibasi A, Levine MM (1994) Salmonella typhi vaccine strain CVD908 expressing the circumsporozoite protein of Plasmodium falciparum: strain construction and safety and immunogenicity in humans. J Infect Dis 169: 927-931
13. Hackett J (1990) Salmonella-based vaccines (review). Vaccine 8: 5-11
14. Hawley-Nelson P, Vousden KH, Hubbert NL, Lowy DR, Schiller JT (1989) HPV 16 E6 and E7 proteins cooperate to immortalize human foreskin keratinocytes. EMBO J 8: 3905-3910
15. Hoiseth SK, Stocker BAD (1981) Aromatic-dependent Salmonella typhimurium are non-virulent and effective as live vaccines. Nature 291: 238
16. Hopkins S, Kraehenbuhl JP, Schodel F, Potts A, Peterson D, de Grandi P, Nardelli-Haefliger D (1995) A recombinant Salmonella typhimurium vaccine induces local immunity by four different routes of immunization. Infect Immun 63: 3279-3286
17. Jarrett WF, Smith KT, O'Neil BW, Gaukroger JM, Chandrachud LM, Grindlay GJ, McGarvie GM, Campo MS (1991) Studies on vaccination against papillomaviruses: prophylactic and therapeutic vaccination with recombinant structural proteins. Virology 184: 33-42
18. Jochmus-Kudielka I, Schneider A, Braun R, Kimmig R, Koldovsky U, Schneweis KE, Seedorf K, Gissmann L (1989) Antibodies against the human papillomavirus type 16 early proteins in human sera: correlation of anti-E7 reactivity with cervical cancer. J Natl Cancer Inst 81: 1698-1704
19. Krul MRL (1994) Immunology of HPV and vaccine development. In: Vermorken AJM, Schermer FAJM (eds) Towards coordination of cancer in Europe, IOS, Amsterdam, pp 121-127
20. Maskell DJ, Sweeney KJ, O'Callaghan D, Hormaeche CE, Liew FY, Dougan G (1987) Salmonella typhimurium aroA mutants as carriers of the Escherichia coli heat-labile enterotoxin B subunit to the murine secretory and systemic immune systems. Microb Pathog 2: 211-221
21. Meneguzzi G, Cerni C, Kieny MP, Lathe R (1991) Immunization against human papillomuvirus type 16 tumor cells with recombinant vaccinia viruses expressing E6 and E7. Virology 181: 62-69
22. Münger K, Phelps WC, Bubb V, Hovvley PM, Schlegel RM (1989) The E6 and E7 genes of human papillomavirus type 16 together are necessary and sufficient for transformation of primary human keratinocytes. J Virol 63: 4417-4421
23. O'Callaghan D, Maskell D, Liew FY, Easmon CS, Dougan G (1988) Characterization of aromatic- and purine-dependent Salmonella typhimurium: attention, persistence, and ability to induce protective immunity in BALB/c mice. Infect Immun 56: 419-423
24. Sambrook J, Fritsch EF, Maniatis T (1989) Molecular cloning: a laboratory manual. Cold Spring Harbor Laboratory, Cold Spring Harbor, New York
25. Schneider-Maunoury S, Croissant O, Orth G (1987) Integration of human papillomavirus type 16 DNA sequences: a possible early event in the progression of genital tumors. J Virol 61: 3295
26. Strugnell RA, Maskell D, Fairweather NF, Pickard D, Cockayne A, Penn C, Dougan G (1990) Stable expression of foreign antigens from the chromosome of Salmonella typhimurium vaccine strains. Gene 88: 57-63
27. Studier FW, Rosenberg AH, Dunn JJ, Dubendorff JW (1990) Use of T7 RNA polymerase to direct expression of cloned genes. Methods Enzymol 185: 60-89
28. Tacket CO, Hone DM, Curtiss R, Kelly SM, Losonsky G, Guers L, Harris AM, Edelman R, Levine MM (1992) Comparison of the safety and immunogenicity of △aroC △aroD and △cya △crp Salmonella typhi strains in adult volunteers. Infect Immun 60: 536-541
29. Tijhaar EJ, Zhengxin Y, Karlas JA, Van Els CACM, Bosch ML, Osterhaus ADME, Meyer TF, Mooi FR (1992) Plasmids that allow the continuous expression of antigens in Salmonella typhimurium at toxic levels. Vaccines '92: 379-384. Cold Spring Harbor Laboratory, Cold Spring Harbor, New York
30. Tijhaar EJ, Zheng-Xin Y, Karlas JA, Meyer TF, Stukart MJ, Osterhaus AD, Mooi FR (1994) Construction and evaluation of an expression vector allowing the stable expression of foreign antigens in a Salmonella typhimurium vaccine strain. Vaccine 12: 1004-1011
31. Wahdan MH, Serie C, Cerisier Y, Sallam S, Germanier R (1982) A controlled field trial of live Salmonella typhi strain Ty 21a oral vaccine against typhoid: three-year results. J Infect Dis 145: 292-295